: . , , Pharmaceutical Forum Team
---------------------------------------------------------------------------------------
Panel I: : , . : Prof. John N. van den Anker, MD, PhD, FCP, FAAP Vice Chair of Paediatrics for Experimental Therapeutics
: "The design of pediatric clinical trials and the relevant scientific and methodological aspects".
----------------------------------------------------------------------------------------
Panel I: : , . :Dr. med. Klaus Rose, klausrose Consulting, Pediatric Drug Development & More : "Ethical, Social, and GCP aspects of drug development in children and paediatric clinical trials".
---------------------------------------------------------------------------------------
Panel I: : , . : Dr. med. Klaus Rose, klausrose Consulting, Pediatric Drug Development & More, Prof. John N. van den Anker, MD, PhD, FCP, FAAP Vice Chair of Paediatrics for Experimental Therapeutics, : . , , /, ,
--------------------------------------------------------------------------------------
: . , Marketing Manager, Healthcare & Pharmaceutical Accounts Manager, PREDICTA
: "Put the Power of Predictive Analytics in the Hands of Clinical Researchers"
---------------------------------------------------------------------------------------
Panel II: , . : Dr. Francis P. Crawley, Executive Director, Good Clinical Practice Alliance - Europe (GCPA)
: "The impact of the EU proposed clinical research regulation on the legal, ethical and social aspects of clinical trials".
-------------------------------------------------------------------------
Panel II: , . : Dr. Richard Torbett, Chief Economist, European Federation of Pharmaceutical Industries and Associations (EFPIA)
---------------------------------------------------------------------------
Panel II: , . :. , , , , .., Dr. Richard Torbett, Chief Economist, European Federation of Pharmaceutical Industries and Associations (EFPIA), Dr. Francis P. Crawley, Executive Director, Good Clinical Practice Alliance - Europe (GCPA), : , M.D., PhD & , , SANOFI,
------------------------------------------------------------------------
Panel III: : .
: , Sr Mgr Development Operations, Amgen Hellas, . , Medical Director, Novartis, . , Medical Director, GlaxoSmithKline, , , , Medical Director, Janssen - Cilag, : . , ,
----------------------------------------------------------------------------
Panel IV: : CRO , .
: . , & , , . , , 401 , , , (), (), . , , : . , Vice President Business development & Marketing, Zein Biotec ------------------------------------------------------------------------